Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70009
Authors: Leili Gao, Linong Ji, Xin Yan, Zhifeng Cheng, Xin Zhang, Wenli Sun, Jianhua Ma, Weihong Song, Yu Liu, Xiaohong Lin, Wuyan Pang, Haixiang Cao, Bo Chen, Zhibin Li, Xianping Lu, the RECAM Study Group
Institutions: Peking University People's Hospital, Jinan Central Hospital, Harbin Medical University, Fourth Affiliated Hospital of Harbin Medical University, Nanjing First Hospital, Chenzhou First People's Hospital, Nanjing Medical University, Zhuzhou Central Hospital, Henan University, Henan University Huaihe Hospital and Huaihe Clinical Institute, Shenzhen Chipscreen Biosciences Co.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413435578